{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:11:51Z","timestamp":1761822711955},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.ijrobp.2004.02.003","type":"journal-article","created":{"date-parts":[[2004,8,31]],"date-time":"2004-08-31T16:30:36Z","timestamp":1093969836000},"page":"130-138","source":"Crossref","is-referenced-by-count":29,"title":["Chemoradiation with raltitrexed (TOMUDEX) in preoperative treatment of stage II-III resectable rectal cancer: A phase II study"],"prefix":"10.1016","volume":"60","author":[{"given":"Maria Antonietta","family":"Gambacorta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessio Giuseppe","family":"Morganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna","family":"Mantini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Miccich\u00e8","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Ratto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Di Miceli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Rotondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Alfieri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovan Battista","family":"Doglietto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Garcia","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonino","family":"De Paoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Numa","family":"Cellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2004.02.003_BIB1","first-page":"571","article-title":"The role of adjuvant radiation in the treatment of rectal cancer","volume":"18","author":"Coia","year":"1991","journal-title":"Semin Oncol"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB2","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199103143241101","article-title":"Effective surgical adjuvant therapy for high-risk rectal carcinoma","volume":"324","author":"Krook","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB3","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1200\/JCO.1997.15.5.2030","article-title":"Adjuvant postoperative fluorouracil-modulated chemotherapy combined with pelvic radiation therapy for rectal cancer","volume":"15","author":"Tepper","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM199408253310803","article-title":"Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery","volume":"331","author":"O'Connell","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB5","series-title":"TNM classification of malignant tumors","year":"1992"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB6","series-title":"ICRU Report 50","year":"1993"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0360-3016(01)01644-3","article-title":"Dislocation of small bowel volume within box pelvic treatment fields, using new \u201cup down table\u201d device","volume":"51","author":"Capirci","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB8","first-page":"1803","article-title":"Treatment of advanced colorectal and gastric adenocarcinomas with 5-FU combined with high-dose folinic acid","volume":"66","author":"Machover","year":"1982","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB9","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting result of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB10","series-title":"Principles and practice of radiation oncology","first-page":"1","article-title":"Overview","author":"Perez","year":"1992"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB11","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0360-3016(97)00918-8","article-title":"Preoperative chemoradiation for extraperitoneal T3 rectal cancer","volume":"40","author":"Valentini","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB12","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1002\/1097-0142(19940601)73:11<2680::AID-CNCR2820731105>3.0.CO;2-C","article-title":"Pathologic assessment of tumor regression grade after preoperative chemoradiotherapy of esophageal carcinoma","volume":"73","author":"Mandard","year":"1994","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB13","doi-asserted-by":"crossref","unstructured":"Wheeler JMD, Warren BF, Mortesen NJMCC, et al. Quantification of histologic regression of rectal cancer after irradiation. Dis Colon Rectum 2002;45,8:1051\u20131056","DOI":"10.1007\/s10350-004-6359-x"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/S1053-4296(97)80024-0","article-title":"Fluoropyrimidine-radiation interactions in cells and tumors","volume":"7","author":"Lawrence","year":"1997","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0167-8140(88)90044-8","article-title":"The search for therapeutic gain in the combination of radiotherapy and chemotherapy","volume":"11","author":"Steel","year":"1988","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB16","first-page":"865","article-title":"Combined effect of X radiation and 5-fluorouracil on survival of transplanted leukemic cells","volume":"47","author":"Vietti","year":"1971","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB17","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/0360-3016(82)90451-5","article-title":"Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X-rays","volume":"8","author":"Byfield","year":"1982","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0360-3016(85)90313-X","article-title":"Phase I and pharmacologic study of 72-hour infused 5-fluorouracil and hyperfractionated cyclical radiation","volume":"11","author":"Byfield","year":"1985","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB19","series-title":"Concomitant continuous infusion chemotherapy and radiation","first-page":"115","article-title":"Theoretical basis and clinical applications of 5-fluorouracil as a radiosensitizer\u2014An overview","author":"Byfield","year":"1991"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB20","first-page":"437","article-title":"Interaction of Tomudex with radiation in vitro and in vivo","volume":"13","author":"Teicher","year":"1998","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB21","first-page":"998","article-title":"Controversial issues in 5-fluorouracil infusion use","volume":"70","author":"Anderson","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB22","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/(SICI)1097-0142(19990815)86:4<710::AID-CNCR21>3.0.CO;2-5","article-title":"Phase I study of 5-fluorouracil administered by protracted venous infusion, leucovorin, and pelvic radiation therapy","volume":"86","author":"Martenson","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB23","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0959-8049(98)00058-6","article-title":"Design of a novel oral fluoropyrimidine carbamate, capacitabine, which generates 5-fluorouracil selectively in tumors by enzymes concentrated in human liver and cancer tissue","volume":"34","author":"Miwa","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB24","first-page":"2948","article-title":"X-ray irradiation induces thymidine phosphorylase and enhances the efficacy of capacitabine (Xeloda) in human cancer xenograft","volume":"5","author":"Sawada","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB25","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1200\/JCO.1998.16.5.1795","article-title":"Preliminary studies of a novel oral fluoropyrimidine carbamate","volume":"16","author":"Budman","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0959-8049(00)00444-5","article-title":"Capacitabine (Xeloda) improves medical resource use compared with 5-fluorouracil plus leucovorin in a phase III trial conducted in patients with advanced colorectal cancer","volume":"37","author":"Twelves","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB27","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1200\/JCO.2002.02.049","article-title":"Phase I trial evaluating the concurrent combination of radiotherapy and capacitabine in rectal cancer","volume":"20","author":"Dunst","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB28","unstructured":"Zalcberg J, Ngan S, Michael M, et al. Observed toxicities in a phase I study of preoperative radiotherapy combined with capacitabine for locally advanced potentially resectable rectal cancer [Abstract]. Proceedings 27th ESMO Congress, Nice, France, Oct 18\u201322, 2002"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0360-3016(02)02856-0","article-title":"Preoperative chemoradiation using oral capacitabine in locally advanced rectal cancer","volume":"54","author":"Kim","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB30","first-page":"1046","article-title":"Enhanced tumoricidal effect of preoperative chemoirradiation using capacitabine for locally advanced rectal cancer","volume":"20","author":"Yoon","year":"2001","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB31","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1200\/JCO.2000.18.20.3529","article-title":"Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer","volume":"18","author":"Hoff","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB32","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/00001813-200211000-00004","article-title":"Phase I trial of oral uracil and tegafur plus leucovorin and pelvic radiation in patients with recurrent rectal cancer","volume":"13","author":"Schiebe","year":"2002","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB33","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0360-3016(99)00225-4","article-title":"Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer","volume":"45","author":"de la Torre","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB34","first-page":"239a","article-title":"Neoadjuvant therapy of rectal carcinoma with UFT-folinic acid (LV) plus radiotherapy (RT)","volume":"18","author":"Feliu","year":"1999","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB35","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0360-3016(01)01728-X","article-title":"Pathologic downstaging of T3\u20134,Nx rectal cancer after chemoradiation","volume":"51","author":"Calvo","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB36","first-page":"5579","article-title":"ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo","volume":"51","author":"Jackman","year":"1991","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB37","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/oxfordjournals.annonc.a059353","article-title":"Folate-based thymidylate synthase inhibitors as anticancer drugs","volume":"6","author":"Jackman","year":"1995","journal-title":"Ann Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.ijrobp.2004.02.003_BIB38","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0959-8049(99)00044-1","article-title":"Raltitrexed (Tomudex) concomitant with radiotherapy as adjuvant treatment for patients with rectal cancer","volume":"35","author":"James","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB39","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/S0959-8049(01)00247-7","article-title":"Preoperative chemoradiation with raltitrexed (\u2018Tomudex\u2019) for T2\/N+ and T3\/N+ rectal cancers","volume":"37","author":"Valentini","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB40","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/S0360-3016(97)00918-8","article-title":"Preoperative chemoradiation for extraperitoneal T3 rectal cancer","volume":"40","author":"Valentini","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB41","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0360-3016(99)00301-6","article-title":"Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer","volume":"45","author":"Valentini","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB42","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0360-3016(01)01618-2","article-title":"Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer","volume":"51","author":"Valentini","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0360-3016(02)03414-4","article-title":"A pathologic score system after preoperative combined modality therapy as a predictor of metastases free survival in the management of rectal carcinoma","volume":"542","author":"Vecchio","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB44","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/0360-3016(95)00020-Y","article-title":"Preoperative infusional chemoradiation therapy for stage T3 rectal cancer","volume":"32","author":"Rich","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB45","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/00000658-199506000-00016","article-title":"Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum","volume":"221","author":"Chari","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.ijrobp.2004.02.003_BIB46","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/BF02055370","article-title":"Preliminary results of preoperative 5-fluorouracil, low-dose leucovorin and concurrent radiation therapy for clinically resectable T3 rectal cancer","volume":"40","author":"Grann","year":"1997","journal-title":"Dis Colon Rectum"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301604002421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301604002421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T02:57:16Z","timestamp":1549249036000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301604002421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0360301604002421"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2004.02.003","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}